COLEPTNCT04034550
Cohort of Hospitalized Patients Suspected of Leptospirosis
StatusActive, Not Recruiting
PhaseNot applicable
Primary completion (estimated)
At risk: Primary completion moved at least 3 months later.
See at-risk trials from Institut National de la Santé Et de la Recherche Médicale, France
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 7 versions: 5 with changes below, 2 re-verified with no change. See every version on ClinicalTrials.gov ↗
- Notable Eligibility criteria expanded, about 4 words
- Primary completion pushed from Sep 6, 2026 to Dec 31, 2026
- Minor Primary completion moved earlier from Jan 6, 2027 to Sep 6, 2026
- Study completion moved earlier from Jul 2027 to Dec 31, 2026
- Minor Trial status: Recruiting to Active, Not Recruiting
- Site details revised at 4 of 4 sites
Notable Trial status: Not Yet Recruiting to Recruitingv3 Show 4 more changesShow less
- Primary completion date: Sep 2025 to Jan 6, 2027
- Start date changed from estimate of Sep 2019 to Jan 6, 2021
- Study sites: 0 to 4
- Study completion date: Sep 2025 to Jul 2027
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
disease severity
Timeframe: 0 to 21 days after onset of symptoms
Arms and interventions
hospitalized patients diagnosed with leptospirosisExperimental
hospitalized patients diagnosed with leptospirosis: 12 months of follow up with biological samples and data collection
Other: Blood and urine sampling and blood banking
Sites
4 sites in 1 country